Publications
modeling (132 POSTS)
2005 (6 POSTS)
Incorporating uncertainty and variability in the assessment of occupational hazards
Bailer AJ, Wheeler MW, Dankovic D, Noble R, Bena J. 2005. Incorporating uncertainty and variability in the assessment of occupational hazards. Int J Risk Assess Manage 5(2-4):344-57; doi: 10.1504/IJRAM.2005.007176.
View AbstractData for physiologically based pharmacokinetic modeling in neonatal animals: physiological parameters in mice and Sprague-Dawley rats
Gentry PR, Haber LT, McDonald TB, Zhao Q, Covington T, Nance P, Clewell HJ III, Lipscomb JC, Barton HA. 2005. Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats. J Children’s Health 2(3–4):363–411; doi: 10.3109/15417060490970430.
View AbstractModel uncertainty and risk estimation for experimental studies of quantal responses
Bailer AJ, Noble RB, Wheeler MW. 2005. Model uncertainty and risk estimation for experimental studies of quantal responses. Risk Anal 25(2):291-9; doi: 10.1111/j.1539-6924.2005.00590.x. PMID: 15876205.
View Abstract2004 (1 POST)
Lessons learned from creating integrated Excel models to calculate human health screening values
Perry CS, Morton E. Lessons learned from creating integrated Excel models to calculate human health screening values. Society for Risk Analysis Annual Meeting, Palm Springs, CA, December 2004.
2003 (1 POST)
Combustion risk modeling and assessment
Haws L. Combustion risk modeling and assessment. Presented at the Texas Commission on Environmental Quality Workshop on Hazardous Waste Combustion, Austin, TX, May 2003.
2001 (3 POSTS)
Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone
Clewell HJ, Gentry PR, Gearhart JM, Covington TR, Banton MI, Andersen ME. 2001. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci 63(2):160–172; doi: 10.1093/toxsci/63.2.160.
View AbstractToward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data
Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, Setzer RW. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data. Toxicol Sci 59(1):37–48; doi: 10.1093/toxsci/59.1.37.
View AbstractToward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: A mathematical construct
Setzer RW, Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol Sci 59(1):49–58; doi: 10.1093/toxsci/59.1.49.
View Abstract2000 (3 POSTS)
Evaluation of biologically based dose-response modeling for developmental toxicity: A workshop report
Lau C, Anderson ME, Crawford-Brown DJ, Kavlock RJ, Kimmel CA, Knudsen TB, Muneoka K, Rogers JM, Setzer RW, Smith G, Tyl R. 2000. Evaluation of biologically based dose-response modeling for developmental toxicity: A workshop report. Regul Toxicol Pharmacol 31(2):190–199; 10.1006/rtph.1999.1360.
View AbstractDevelopment of a physiologically-based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment
Clewell HJ III, Gentry PR, Allen BC, Covington TR, Gearhart JM. 2000. Development of a physiologically-based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(Suppl 2):283–305; doi: 10.1289/ehp.00108s2283.
View AbstractInvestigation of the impact of benchmark and PBPK modeling on the derivation of MRLs
Gentry R, Clewell H, Covington T, Wilson J. Investigation of the impact of benchmark and PBPK modeling on the derivation of MRLs. Poster presented at Society of Toxicology 39th Annual Meeting, Philadelphia, PA, March 2000.
1999 (1 POST)
Developing a physiologically based pharmacokinetic model to describe methylene chloride kinetics at the subcellular level
Rish W, Kirman CR, Hays SM, Gargas ML, Andersen ME, Reitz RH, Guengerich FP, Green T, McConnell EE, Buckpit A, Voytek P, Dugard PH. 1999. Developing a physiologically based pharmacokinetic model to describe methylene chloride kinetics at the subcellular level. Toxicologist 48, Paper No. 671. Presented at Society of Toxicology 38th Annual Meeting, New Orleans, LA, March 1999.